3 Expert Perspectives on Biosimilar Differentiation & Biobetter Development
Biosimilar Development is dedicated to presenting technical information and thought-leadership columns on the biosimilar development, regulatory, policy, and commercialisation advances in the global biosimilar industry.
As an active participant in the biosimilar conferences circuit, Chief Editor Anna Rose Welch has been appointed chair or served as a speaker and panel moderator at conferences based in the U.S. and Europe, including the World Biosimilar Congress USA, The Biotech Pharma Summit, the CBI Biosimilars Summit, DIA Biosimilars Conference, and the Biosimilar Medicines Group Conference.
In this article, George I’ons, head of product strategy and insights for Owen Mumford, talks about some of the biggest considerations companies must make about the device platform. Get the full story here.